SYMPOSIUM: THE DIFFERENT ASPECTS OF SCHIZOPHRENIA TREATMENT
Summary of presentations on schizophrenia treatment and role of cariprazine during a satellite symposium held during the 28th European Congress of Psychiatry.
SYMPOSIUM: THE DIFFERENT ASPECTS OF SCHIZOPHRENIA TREATMENT
Summary of presentations on schizophrenia treatment and role of our product during a satellite symposium held during the 28th European Congress of Psychiatry.
COD: 300020/R30
ANTIPSYCHOTIC MONOTHERAPY OR POLYPHARMACY: WHAT’S THE EVIDENCE?
There is emerging observational evidence that some combinations of antipsychotics might be beneficial but monotherapy remains the standard of practice.
BEST OF 2019: ARTICLE OVERVIEW OF RESEARCH IN SCHIZOPHRENIA
During an educational symposium at the EPA 2020 Congress, Prof. Pierre-Michel Llorca highlighted some of the notable research articles published in 2019.
GREATER EFFORTS NEEDED TO INTEGRATE CARE FOR PEOPLE WITH SCHIZOPHRENIA
There is a need to increase the use of integrated care for schizophrenia to improve the real-life functional outcomes of people with the illness.
BOOK REVIEW: MANAGING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA
Managing negative symptoms of schizophrenia is the subject of a new book published by Oxford University Press and highlighted at the virtual 28th EPA Congress.
COD: 300020/R33
ADDRESSING FUNCTIONING IN SCHIZOPHRENIA
Schizophrenia treatment today is much more focused on overall recovery than just response or remission. The goal is to help people function as normally as possible in real life, said Prof. Peter Falkai, Ludwig-Maximilian University Munich, Germany
METACOGNITION KEY TO IMPROVING FUNCTIONING IN SCHIZOPHRENIA?
Professor Dame Til Wykes discussed new developments in cognitive remediation for schizophrenia at the virtual 28th European Congress of Psychiatry.
